This Biogen Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
NIO
American Express Company
Capital One Financial Corp
Biogen Inc.
Keysight Technologies Inc
NIO NIO | 0.00 | |
American Express Company AXP | 0.00 | |
Capital One Financial Corp COF | 0.00 | |
Biogen Inc. BIIB | 0.00 | |
Keysight Technologies Inc KEYS | 0.00 |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Goldman Sachs analyst Tina Hou upgraded Nio Inc – ADR (NYSE:NIO) from Neutral to Buy and announced a $7 price target. Nio shares closed at $4.78 on Friday. See how other analysts view this stock.
- HSBC analyst Saul Martinez upgraded Capital One Financial Corp (NYSE:COF) from Hold to Buy and raised the price target from $226 to $229. Capital One Financial shares closed at $201.52 on Friday. See how other analysts view this stock.
- Morgan Stanley analyst Meta Marshall upgraded Keysight Technologies Inc (NYSE:KEYS) from Equal-Weight to Overweight and raised the price target from $350 to $400. Keysight shares closed at $322.05 on Friday. See how other analysts view this stock.
- Truist Securities analyst Srikripa Devarakonda upgraded Biogen Inc (NASDAQ:BIIB) from Hold to Buy and boosted the price target from $190 to $235. Biogen shares closed at $199.15 on Friday. See how other analysts view this stock.
- JP Morgan analyst Richard Shane upgraded American Express Co (NYSE:AXP) from Neutral to Overweight and raised the price target from $328 to $400. American Express shares closed at $350.58 on Friday. See how other analysts view this stock.
Considering buying BIIB stock? Here’s what analysts think:
Photo via Shutterstock
